Holen Sie sich die Stockscreener-App
13.17
8.66%
1.05
Handel nachbörslich:
13.12
-0.05
-0.38%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AUPH?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$12.12
Offen:
$12.21
24-Stunden-Volumen:
2.63M
Relative Volume:
1.36
Marktkapitalisierung:
$1.73B
Einnahmen:
$260.11M
Nettoeinkommen (Verlust:
$60.64M
KGV:
30.63
EPS:
0.43
Netto-Cashflow:
$92.29M
1W Leistung:
+10.77%
1M Leistung:
+19.19%
6M Leistung:
+59.83%
1J Leistung:
+82.66%
1-Tages-Spanne:
$12.07
$13.30
1-Wochen-Bereich:
$11.88
$13.30
52-Wochen-Spanne:
$6.55
$13.54
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
Firmenname
Aurinia Pharmaceuticals Inc
Sektor
Branche
Telefon
250-744-2487
Adresse
#140, 14315 - 118 AVENUE, EDMONTON, BC
Vergleichen Sie AUPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
13.17 | 1.60B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-05-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-01-25 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-05-05 | Eingeleitet | Cowen | Outperform |
| 2020-01-10 | Eingeleitet | Jefferies | Buy |
| 2019-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-16 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-02-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-22 | Bestätigt | FBR & Co. | Outperform |
| 2016-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2016-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-08 | Eingeleitet | MLV & Co | Buy |
Alle ansehen
Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits
FDA Official Steps Down, Sued by Drugmaker - The Wall Street Journal
Key metrics from Aurinia Pharmaceuticals Inc.’s quarterly dataTrade Exit Summary & Reliable Intraday Trade Alerts - newser.com
Will Aurinia Pharmaceuticals Inc. stock recover faster than market2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
What analysts say about Aurinia Pharmaceuticals Inc IKAP stockMACD Trading Signals & Double Digit Wealth Tips - earlytimes.in
Visualizing Aurinia Pharmaceuticals Inc. stock with heatmaps2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
Chart overlay techniques for tracking Aurinia Pharmaceuticals Inc.Market Performance Summary & Community Consensus Picks - newser.com
Why Aurinia Pharmaceuticals Inc. is moving todayEarnings Overview Report & Real-Time Buy Zone Alerts - newser.com
Using R and stats models for Aurinia Pharmaceuticals Inc. forecastingProfit Target & Weekly Market Pulse Alerts - newser.com
Can Aurinia Pharmaceuticals Inc. stock reach $100 price targetJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - newser.com
Is There An Opportunity With Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) 49% Undervaluation? - Yahoo Finance
Analyzing drawdowns of Aurinia Pharmaceuticals Inc. with statistical toolsQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
Is Aurinia Pharmaceuticals Inc. (IKAP) stock undervalued historicallyMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Aurinia Pharmaceuticals (AUPH) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Using data models to predict Aurinia Pharmaceuticals Inc. stock movementJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Is Aurinia Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Combining price and volume data for Aurinia Pharmaceuticals Inc.Weekly Profit Report & Detailed Earnings Play Strategies - newser.com
Is Aurinia Pharmaceuticals Inc. building a consolidation baseMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
Will breakout in Aurinia Pharmaceuticals Inc. lead to full recoveryTrade Volume Report & High Conviction Trade Alerts - newser.com
Is Aurinia Pharmaceuticals Inc. (IKAP) stock a good hedge against inflation2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
Is Aurinia Pharmaceuticals Inc. stock vulnerable to regulatory risksAnalyst Downgrade & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
Finanzdaten der Aurinia Pharmaceuticals Inc-Aktie (AUPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):